Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK

by Elisabeth Fenwick, Alan Martin, Melanie Schroeder, Stuart J. Mealing, Oyinkansola Solanke, Nancy Risebrough, Afisi S. Ismaila
Published 2021-03-01

Cost-effectiveness analysis of a single-inhaler triple therapy for patients with advanced chronic obstructive pulmonary disease (COPD) using the FULFIL trial: A UK perspective

by Melanie Schroeder, Dhvani Shah, Nancy Risebrough, Alan Martin, Shiyuan Zhang, Kerigo Ndirangu, Andrew Briggs, Afisi S. Ismaila
Published 2019-01-01